San Leandro, CA – According to filings with the U.S. Securities and Exchange Commission, Mercator Medsystems is raising $14,999,997.00 in a new round of investment. Sources indicate as part of senior management Chief Executive Officer, Trent Reutiman played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Mercator Medsystems

Mercator MedSystems, Inc. is a medical technology company focused on the treatment of peripheral artery disease using its catheter-guided, micro-infusion systems for site-specific, non-systemic delivery of therapeutic agents directly across any blood vessel. The company’s technology also enables therapies for vascular diseases, hypertension, oncology and regenerative medicine. The company’s Bullfrog« and Blowfish« Micro-Infusion Devices are the first systems able to infuse drugs, genes and cells safely through blood vessel or airway walls into deep tissues without major surgery.

To learn more about Mercator Medsystems, visit http://www.mercatormed.com/

Contact:
Trent Reutiman, Chief Executive Officer
510-614-4550
trentreutiman@mercatormed.com
https://www.linkedin.com/in/trent-reutiman-5193093/

SOURCE: http://www.intelligence360.io
Copyright (c) 2019 SI360 Inc. All rights reserved